PRELUDE CAPITAL MANAGEMENT, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 52 filers reported holding CTI BIOPHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2017$3,000
-96.9%
900
-96.2%
0.00%
-100.0%
Q1 2017$98,000–23,400–0.01%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2017.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders